Beobachtungsplan, NIS 684: Enhanced passive safety surveillance of VaxigripTetra® (quadrivalent inactivated split virion influenza vaccine, intramuscular route) and Efluelda® (high dose quadrivalent inactivated split virion influenza vaccine, intramuscular route) vaccines in Europe during the influenza season 2022/23.

Datei

• Artikel "Beobachtungsplan, NIS 684: Enhanced passive safety surveillance of VaxigripTetra® (quadrivalent inactivated split virion influenza vaccine, intramuscular route) and Efluelda® (high dose quadrivalent inactivated split virion influenza vaccine, intramuscular route) vaccines in Europe during the influenza season 2022/23."Herunterladen(PDF, 2MB, Datei ist nicht barrierefrei)